Tag: post-approval drug monitoring
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Categories
Medications
Archives
Recent-posts
Vanadium: The Dietary Supplement You Didn't Know You Needed
Sep, 4 2023
Goldenseal and Metformin Interaction Risks for Blood Sugar Control
Dec, 30 2025
Prescriber Education Resources: Essential Guides for Doctors on Generic Medications
Jan, 7 2026
Black Box Warnings: What You Need to Know About the FDA’s Strongest Drug Safety Alerts
Nov, 19 2025
Alternatives to Sumatriptan: Exploring the Options for Migraine Relief
Mar, 28 2025